CLDX · Celldex Therapeutics, Inc. · Held by Funds
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of CLDX by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 16.05% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 3.35% | 2,632,706 |
| Index ETFs | 12.70% | 9,972,640 |
| Active ETFs | 0.77% | 608,289 |
| Active funds | 21.45% | 16,846,774 |
| Unclassified | 0.10% | 75,214 |
| All registered funds | 38.37% | 30,135,623 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding CLDX
256 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD HEALTH CARE FUND | — | 3,783,994 | $144,018,812 | 0.38% | Long | 2026-07-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 2,487,758 | $92,569,475 | 0.00% | Long | 2026-06-30 | |
| iShares Russell 2000 ETF | IWM | 2,032,138 | $75,615,855 | 0.09% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 2,026,087 | $75,390,697 | 0.70% | Long | 2026-06-30 | |
| VANGUARD EXPLORER FUND | — | 1,447,608 | $55,095,960 | 0.25% | Long | 2026-07-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 1,254,603 | $46,683,778 | 0.32% | Long | 2026-06-30 | |
| Eventide Healthcare & Life Sciences Fund | — | 1,037,000 | $38,586,770 | 2.16% | Long | 2026-06-30 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 970,814 | $36,123,989 | 0.37% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 897,530 | $33,397,091 | 0.03% | Long | 2026-06-30 | |
| Fidelity Small Cap Index Fund | FSSNX | 854,702 | $32,529,958 | 0.10% | Long | 2026-07-31 | |
| Select Biotechnology Portfolio | FBIOX | 778,500 | $30,851,955 | 0.49% | Long | 2026-08-31 | |
| Small Cap Growth Fund | — | 793,241 | $30,190,752 | 0.54% | Long | 2026-07-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | FCTDX | 596,180 | $23,626,613 | 0.01% | Long | 2026-08-31 | |
| iShares Russell 2000 Growth ETF | IWO | 579,456 | $21,561,558 | 0.14% | Long | 2026-06-30 | |
| Federated Hermes Kaufmann Fund | — | 530,328 | $20,184,284 | 0.41% | Long | 2026-07-31 | |
| Fidelity Advisor Biotechnology Fund | — | 512,352 | $19,500,117 | 0.89% | Long | 2026-07-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 494,692 | $18,407,489 | 0.15% | Long | 2026-06-30 | |
| Fidelity Small Cap Growth Fund | — | 473,857 | $18,034,997 | 0.20% | Long | 2026-07-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 447,761 | $17,744,768 | 0.10% | Long | 2026-08-31 | |
| Fidelity Small Cap Discovery Fund | FSCRX | 433,584 | $16,502,207 | 0.73% | Long | 2026-07-31 | |
| Fidelity Extended Market Index Fund | FSMAX | 384,433 | $15,235,080 | 0.04% | Long | 2026-08-31 | |
| Nuveen Quant Small Cap Equity Fund | — | 394,000 | $14,995,640 | 0.37% | Long | 2026-07-31 | |
| Schwab U.S. Small-Cap ETF | SCHA | 373,156 | $14,788,172 | 0.07% | Long | 2026-08-31 | |
| Fidelity Series Small Cap Discovery Fund | FJACX | 376,700 | $14,337,202 | 0.73% | Long | 2026-07-31 | |
| Federated Hermes Kaufmann Small Cap Fund | — | 324,614 | $12,354,809 | 0.43% | Long | 2026-07-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 256,436 | $10,162,559 | 0.18% | Long | 2026-08-31 | |
| Fidelity Small Cap Growth K6 Fund | FOCSX | 237,705 | $9,047,052 | 0.20% | Long | 2026-07-31 | |
| U.S. SMALL CAP PORTFOLIO | DFSTX | 235,633 | $8,968,192 | 0.05% | Long | 2026-07-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 207,473 | $8,222,155 | 0.04% | Long | 2026-08-31 | |
| Driehaus Small Cap Growth Fund | — | 209,317 | $7,788,686 | 0.48% | Long | 2026-06-30 | |
| Dimensional U.S. Small Cap ETF | DFAS | 202,557 | $7,709,319 | 0.05% | Long | 2026-07-31 | |
| Schwab Small-Cap Index Fund | SWSSX | 189,866 | $7,226,300 | 0.10% | Long | 2026-07-31 | |
| U.S. MICRO CAP PORTFOLIO | DFSCX | 170,131 | $6,475,186 | 0.08% | Long | 2026-07-31 | |
| Small Cap Growth Stock Portfolio | — | 157,966 | $5,877,915 | 0.65% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 148,169 | $5,871,937 | 0.00% | Long | 2026-08-31 | |
| NORTH SQUARE DYNAMIC SMALL CAP FUND | — | 144,563 | $5,729,032 | 0.81% | Long | 2026-08-31 | |
| Fidelity Series Small Cap Core Fund | FSSLX | 150,228 | $5,717,678 | 0.36% | Long | 2026-07-31 | |
| THE HARTFORD SMALL COMPANY FUND | — | 149,519 | $5,690,693 | 0.84% | Long | 2026-07-31 | |
| Goldman Sachs Small Cap Value Insights Fund | — | 149,141 | $5,676,306 | 0.43% | Long | 2026-07-31 | |
| Master Small Cap Index Series | — | 144,890 | $5,391,357 | 0.09% | Long | 2026-06-30 | |
| T. Rowe Price Small-Mid Cap ETF | TMSL | 139,948 | $5,207,465 | 0.19% | Long | 2026-06-30 | |
| iShares Russell 2000 Value ETF | IWN | 138,378 | $5,149,045 | 0.04% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 122,173 | $4,841,716 | 0.00% | Long | 2026-08-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 116,397 | $4,331,132 | 0.00% | Long | 2026-06-30 | |
| Goldman Sachs Small Cap Equity Insights Fund | — | 105,866 | $4,029,260 | 0.40% | Long | 2026-07-31 | |
| T.Rowe Price Small Cap Growth Portfolio | — | 108,123 | $4,023,257 | 0.36% | Long | 2026-06-30 | |
| THE HARTFORD HEALTHCARE FUND | — | 104,861 | $3,991,010 | 0.52% | Long | 2026-07-31 | |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund | — | 106,117 | $3,948,614 | 0.20% | Long | 2026-06-30 | |
| Nuveen Small Cap Blend Index Fund | — | 103,484 | $3,938,601 | 0.10% | Long | 2026-07-31 | |
| ALPS Medical Breakthroughs ETF | SBIO | 96,637 | $3,829,724 | 1.60% | Long | 2026-08-31 |